1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of LPAR1 mRNA CTD PMID:30723492 1-octadec-9-enoylglycero-3-phosphate increases response to substance ISO RGD:731581 6480464 LPAR1 protein results in increased susceptibility to lysophosphatidic acid CTD PMID:16809448 1-octadec-9-enoylglycero-3-phosphate multiple interactions ISO RGD:731581 6480464 LPAR1 protein affects the reaction [lysophosphatidic acid results in increased stability of and affects the localization of NFE2L2 protein] more ... CTD PMID:16224106 , PMID:25398768 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of LPAR1 mRNA CTD PMID:12075121 , PMID:15901920 17beta-estradiol affects expression ISO RGD:731581 6480464 Estradiol affects the expression of LPAR1 mRNA CTD PMID:14699072 17beta-estradiol increases expression ISO RGD:731582 6480464 Estradiol results in increased expression of LPAR1 mRNA CTD PMID:19484750 17beta-estradiol multiple interactions ISO RGD:731581 6480464 [Estradiol binds to ESR2 protein] which results in increased expression of LPAR1 mRNA CTD PMID:20404318 17beta-estradiol affects expression ISO RGD:731582 6480464 Estradiol affects the expression of LPAR1 mRNA CTD PMID:15598610 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:731581 6480464 Tetrachlorodibenzodioxin results in decreased expression of LPAR1 mRNA CTD PMID:19684285 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of LPAR1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:731582 6480464 Tetrachlorodibenzodioxin affects the expression of LPAR1 mRNA CTD PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:731582 6480464 Tetrachlorodibenzodioxin results in decreased expression of LPAR1 mRNA CTD PMID:18691609 2-methylcholine affects expression ISO RGD:731581 6480464 beta-methylcholine affects the expression of LPAR1 mRNA CTD PMID:21179406 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:731582 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of LPAR1 mRNA CTD PMID:26251327 4,4'-sulfonyldiphenol increases expression ISO RGD:731581 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of LPAR1 mRNA CTD PMID:30616060 4,4'-sulfonyldiphenol increases expression ISO RGD:731582 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of LPAR1 mRNA CTD PMID:30951980 4-hydroxynon-2-enal increases expression ISO RGD:731582 6480464 4-hydroxy-2-nonenal results in increased expression of LPAR1 mRNA CTD PMID:19191707 4-hydroxyphenyl retinamide increases expression ISO RGD:731582 6480464 Fenretinide results in increased expression of LPAR1 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine multiple interactions ISO RGD:731581 6480464 [Decitabine co-treated with Vorinostat] affects the expression of LPAR1 mRNA CTD PMID:17330099 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of LPAR1 mRNA CTD PMID:24780913 , PMID:25825206 acrolein decreases expression ISO RGD:731582 6480464 Acrolein results in decreased expression of LPAR1 mRNA CTD PMID:18515264 all-trans-retinoic acid decreases expression ISO RGD:731581 6480464 Tretinoin results in decreased expression of LPAR1 mRNA CTD PMID:21934132 all-trans-retinoic acid increases expression ISO RGD:731581 6480464 Tretinoin results in increased expression of LPAR1 mRNA CTD PMID:23724009 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of LPAR1 mRNA CTD PMID:16483693 aristolochic acid A decreases expression ISO RGD:731581 6480464 aristolochic acid I results in decreased expression of LPAR1 mRNA CTD PMID:33212167 atrazine decreases expression ISO RGD:731581 6480464 Atrazine results in decreased expression of LPAR1 mRNA CTD PMID:22378314 belinostat decreases expression ISO RGD:731581 6480464 belinostat results in decreased expression of LPAR1 mRNA CTD PMID:27188386 benzo[a]pyrene increases mutagenesis ISO RGD:731581 6480464 Benzo(a)pyrene results in increased mutagenesis of LPAR1 gene CTD PMID:25435355 benzo[a]pyrene decreases methylation ISO RGD:731581 6480464 Benzo(a)pyrene results in decreased methylation of LPAR1 promoter CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:731581 6480464 Benzo(a)pyrene results in increased methylation of LPAR1 3' UTR, Benzo(a)pyrene results in increased methylation of LPAR1 5' UTR CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:731582 6480464 Benzo(a)pyrene results in increased expression of LPAR1 mRNA CTD PMID:22228805 benzo[a]pyrene diol epoxide I affects expression ISO RGD:731581 6480464 7 more ... CTD PMID:20382639 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of LPAR1 mRNA CTD PMID:18164116 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of LPAR1 mRNA CTD PMID:12075121 more ... bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of LPAR1 gene CTD PMID:28505145 bisphenol A increases expression ISO RGD:731582 6480464 bisphenol A results in increased expression of LPAR1 mRNA CTD PMID:25594700 , PMID:30951980 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of LPAR1 mRNA CTD PMID:25181051 bisphenol F increases expression ISO RGD:731582 6480464 bisphenol F results in increased expression of LPAR1 mRNA CTD PMID:30951980 butan-1-ol multiple interactions ISO RGD:731581 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of LPAR1 mRNA CTD PMID:29432896 butanal decreases expression ISO RGD:731581 6480464 butyraldehyde results in decreased expression of LPAR1 mRNA CTD PMID:26079696 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of LPAR1 mRNA CTD PMID:19167457 calcitriol decreases expression ISO RGD:731581 6480464 Calcitriol results in decreased expression of LPAR1 mRNA CTD PMID:26485663 chloroprene increases expression ISO RGD:731582 6480464 Chloroprene results in increased expression of LPAR1 mRNA CTD PMID:23125180 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of LPAR1 mRNA CTD PMID:23125180 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of LPAR1 mRNA CTD PMID:18668222 choline multiple interactions ISO RGD:731582 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of LPAR1 gene, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LPAR1 mRNA CTD PMID:20938992 chromium(6+) affects expression ISO RGD:731582 6480464 chromium hexavalent ion affects the expression of LPAR1 mRNA CTD PMID:28472532 cisplatin decreases expression ISO RGD:731582 6480464 Cisplatin results in decreased expression of LPAR1 mRNA CTD PMID:21151649 clothianidin decreases expression ISO RGD:731581 6480464 clothianidin results in decreased expression of LPAR1 mRNA CTD PMID:31626844 cocaine decreases expression ISO RGD:731581 6480464 Cocaine results in decreased expression of LPAR1 mRNA CTD PMID:15009677 corticosterone increases expression EXP 6480464 Corticosterone results in increased expression of LPAR1 mRNA CTD PMID:15755911 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of LPAR1 mRNA CTD PMID:26577399 , PMID:27523638 curcumin decreases expression ISO RGD:731581 6480464 Curcumin results in decreased expression of LPAR1 mRNA CTD PMID:17999991 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of LPAR1 mRNA CTD PMID:21266533 , PMID:24893172 dorsomorphin multiple interactions ISO RGD:731581 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin affects response to substance ISO RGD:731581 6480464 LPAR1 protein affects the susceptibility to Doxorubicin CTD PMID:16217747 elemental selenium increases expression ISO RGD:731581 6480464 Selenium results in increased expression of LPAR1 mRNA CTD PMID:19244175 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of LPAR1 mRNA CTD PMID:29391264 ethanol multiple interactions ISO RGD:731582 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of LPAR1 mRNA CTD PMID:30517762 ethanol affects splicing ISO RGD:731582 6480464 Ethanol affects the splicing of LPAR1 mRNA CTD PMID:30319688 ethanol increases expression ISO RGD:731582 6480464 Ethanol results in increased expression of LPAR1 mRNA CTD PMID:30319688 ethyl methanesulfonate decreases expression ISO RGD:731581 6480464 Ethyl Methanesulfonate results in decreased expression of LPAR1 mRNA CTD PMID:23649840 flavonoids increases expression EXP 6480464 Flavonoids results in increased expression of LPAR1 mRNA CTD PMID:18035473 folic acid multiple interactions ISO RGD:731582 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of LPAR1 gene, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LPAR1 mRNA CTD PMID:20938992 folic acid increases expression ISO RGD:731582 6480464 Folic Acid results in increased expression of LPAR1 mRNA CTD PMID:25006883 fonofos increases methylation ISO RGD:731581 6480464 Fonofos results in increased methylation of LPAR1 promoter CTD PMID:22847954 furan increases expression EXP 6480464 furan results in increased expression of LPAR1 mRNA CTD PMID:27387713 genistein increases expression EXP 6480464 Genistein results in increased expression of LPAR1 mRNA CTD PMID:12075121 hydrazine decreases expression ISO RGD:731582 6480464 hydrazine results in decreased expression of LPAR1 mRNA CTD PMID:15282401 iron atom decreases expression EXP 6480464 Iron deficiency results in decreased expression of LPAR1 mRNA CTD PMID:19821111 iron(0) decreases expression EXP 6480464 Iron deficiency results in decreased expression of LPAR1 mRNA CTD PMID:19821111 L-methionine multiple interactions ISO RGD:731582 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of LPAR1 gene, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LPAR1 mRNA CTD PMID:20938992 lead(0) decreases expression ISO RGD:731581 6480464 Lead results in decreased expression of LPAR1 mRNA CTD PMID:19921347 lead(0) affects expression ISO RGD:731581 6480464 Lead affects the expression of LPAR1 mRNA CTD PMID:28903495 lead(2+) decreases expression ISO RGD:731581 6480464 Lead results in decreased expression of LPAR1 mRNA CTD PMID:19921347 lead(2+) affects expression ISO RGD:731581 6480464 Lead affects the expression of LPAR1 mRNA CTD PMID:28903495 lipopolysaccharide multiple interactions ISO RGD:731582 6480464 3 more ... CTD PMID:21821728 , PMID:25843059 lipopolysaccharide affects response to substance ISO RGD:731582 6480464 LPAR1 affects the susceptibility to Lipopolysaccharides CTD PMID:21821728 lipopolysaccharide increases expression ISO RGD:731582 6480464 Lipopolysaccharides results in increased expression of LPAR1 mRNA, Lipopolysaccharides results in increased expression of LPAR1 protein CTD PMID:21821728 , PMID:25843059 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of LPAR1 mRNA CTD PMID:28801915 methotrexate affects response to substance ISO RGD:731581 6480464 LPAR1 protein affects the susceptibility to Methotrexate CTD PMID:16217747 methoxychlor increases methylation EXP 6480464 Methoxychlor results in increased methylation of LPAR1 gene CTD PMID:23303685 methyl beta-cyclodextrin multiple interactions ISO RGD:731582 6480464 methyl-beta-cyclodextrin inhibits the reaction [Lipopolysaccharides promotes the reaction [LPAR1 protein binds to CD14 protein]] CTD PMID:21821728 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of LPAR1 mRNA CTD PMID:28801915 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of LPAR1 mRNA CTD PMID:18164116 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of LPAR1 mRNA CTD PMID:25729387 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of LPAR1 mRNA CTD PMID:25729387 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of LPAR1 mRNA CTD PMID:33387578 parathion increases methylation ISO RGD:731581 6480464 Parathion results in increased methylation of LPAR1 promoter CTD PMID:22847954 perfluorooctane-1-sulfonic acid affects expression EXP 6480464 perfluorooctane sulfonic acid affects the expression of LPAR1 mRNA CTD PMID:20136073 phenylmercury acetate decreases expression ISO RGD:731581 6480464 Phenylmercuric Acetate results in decreased expression of LPAR1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:731581 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LPAR1 mRNA CTD PMID:27188386 progesterone increases expression EXP 6480464 Progesterone results in increased expression of LPAR1 mRNA CTD PMID:20726854 SB 431542 multiple interactions ISO RGD:731581 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 selenium atom increases expression ISO RGD:731581 6480464 Selenium results in increased expression of LPAR1 mRNA CTD PMID:19244175 silver atom decreases expression ISO RGD:731582 6480464 Silver results in decreased expression of LPAR1 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:731582 6480464 Silver results in decreased expression of LPAR1 mRNA CTD PMID:27131904 sodium fluoride decreases expression ISO RGD:731582 6480464 Sodium Fluoride results in decreased expression of LPAR1 mRNA CTD PMID:27862939 succimer multiple interactions ISO RGD:731582 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of LPAR1 mRNA CTD PMID:21641980 terbufos increases methylation ISO RGD:731581 6480464 terbufos results in increased methylation of LPAR1 promoter CTD PMID:22847954 tetrachloromethane affects expression ISO RGD:731582 6480464 Carbon Tetrachloride affects the expression of LPAR1 mRNA CTD PMID:17484886 tetrachloromethane multiple interactions ISO RGD:731582 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of LPAR1 mRNA CTD PMID:30517762 tipifarnib increases expression EXP 6480464 tipifarnib results in increased expression of LPAR1 mRNA CTD PMID:16403772 titanium dioxide increases expression ISO RGD:731582 6480464 titanium dioxide results in increased expression of LPAR1 mRNA CTD PMID:23557971 , PMID:27760801 titanium dioxide affects expression ISO RGD:731582 6480464 titanium dioxide affects the expression of LPAR1 mRNA CTD PMID:17656681 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of LPAR1 mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of LPAR1 mRNA CTD PMID:25729387 trichostatin A decreases expression ISO RGD:731581 6480464 trichostatin A results in decreased expression of LPAR1 mRNA CTD PMID:26272509 trichostatin A multiple interactions ISO RGD:731581 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LPAR1 mRNA CTD PMID:27188386 triclosan increases expression ISO RGD:731581 6480464 Triclosan results in increased expression of LPAR1 mRNA CTD PMID:30510588 triptonide decreases expression ISO RGD:731582 6480464 triptonide results in decreased expression of LPAR1 mRNA CTD PMID:33045310 undecane increases expression EXP 6480464 undecane results in increased expression of LPAR1 protein CTD PMID:17337753 valproic acid increases expression ISO RGD:731581 6480464 Valproic Acid results in increased expression of LPAR1 mRNA CTD PMID:19101580 valproic acid multiple interactions ISO RGD:731581 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LPAR1 mRNA CTD PMID:27188386 valproic acid decreases expression ISO RGD:731581 6480464 Valproic Acid results in decreased expression of LPAR1 mRNA CTD PMID:23179753 more ... valproic acid increases expression ISO RGD:731582 6480464 Valproic Acid results in increased expression of LPAR1 mRNA CTD PMID:19136453 , PMID:24896083 valproic acid affects expression ISO RGD:731581 6480464 Valproic Acid affects the expression of LPAR1 mRNA CTD PMID:25979313 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of LPAR1 mRNA CTD PMID:23665938 vincaleukoblastine affects response to substance ISO RGD:731581 6480464 LPAR1 protein affects the susceptibility to Vinblastine CTD PMID:16217747 vitamin E increases expression ISO RGD:731581 6480464 Vitamin E results in increased expression of LPAR1 mRNA CTD PMID:19244175 vorinostat multiple interactions ISO RGD:731581 6480464 [decitabine co-treated with vorinostat] affects the expression of LPAR1 mRNA CTD PMID:17330099 zaragozic acid A decreases expression EXP 6480464 squalestatin 1 results in decreased expression of LPAR1 mRNA CTD PMID:27225895 zaragozic acid A increases expression ISO RGD:731582 6480464 squalestatin 1 results in increased expression of LPAR1 mRNA CTD PMID:27225895